4th Quarter - Termination Amendment

RICCHETTI INCORPORATED for NOVARTIS

Firm
Client
Income
$30,000
Expenses
—
Terminated
Jan 1, 2012

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

issues related to patent reform

Foreign entity interest: Novartis is owned by Novartis AG, Basel, Switzerland

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

Issues related to importation of prescription drugs issues affecting pharmaceutical manufacturers in HR 3590, the Patient Protection and Affordable Care Act issues related to coverage of vaccines in the Patient Protection and Affordable Care Act issues related to FDA approval process for adjuvanted vaccines

Foreign entity interest: Novartis is owned by Novartis AG, Basel, Switzerland

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3590 (112th)

Medicare/Medicaid MMM

issues related to pharmaceutical reimbursement and Medicaid rebates issues affecting pharmaceutical manufacturers in HR 3590, the Patient Protection and Affordable Care Act

Foreign entity interest: Novartis is owned by Novartis AG, Basel, Switzerland

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3590 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.